Aptose Biosciences (APS) Competitors C$1.57 -0.03 (-1.88%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesBuy This Stock APS vs. NEPT, ATE, SBM, IMV, IOT, QPT, KNE, RVV, PBS, and MFSShould you be buying Aptose Biosciences stock or one of its competitors? The main competitors of Aptose Biosciences include Neptune Wellness Solutions (NEPT), Antibe Therapeutics (ATE), Sirona Biochem (SBM), IMV (IMV), Innovotech (IOT), Quest PharmaTech (QPT), Kane Biotech (KNE), Revive Therapeutics (RVV), Pacgen Life Science Co. (PBS.V) (PBS), and Medifocus Inc. (MFS.V) (MFS). These companies are all part of the "biotechnology" industry. Aptose Biosciences vs. Its Competitors Neptune Wellness Solutions Antibe Therapeutics Sirona Biochem IMV Innovotech Quest PharmaTech Kane Biotech Revive Therapeutics Pacgen Life Science Co. (PBS.V) Medifocus Inc. (MFS.V) Aptose Biosciences (TSE:APS) and Neptune Wellness Solutions (TSE:NEPT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment. Does the media prefer APS or NEPT? In the previous week, Aptose Biosciences' average media sentiment score of 0.00 equaled Neptune Wellness Solutions'average media sentiment score. Company Overall Sentiment Aptose Biosciences Neutral Neptune Wellness Solutions Neutral Do institutionals & insiders hold more shares of APS or NEPT? 0.0% of Aptose Biosciences shares are held by institutional investors. 17.1% of Aptose Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is APS or NEPT more profitable? Aptose Biosciences' return on equity of 1,017.48% beat Neptune Wellness Solutions' return on equity.Company Net Margins Return on Equity Return on Assets Aptose BiosciencesN/A 1,017.48% -136.29% Neptune Wellness Solutions N/A N/A N/A Which has preferable earnings & valuation, APS or NEPT? Aptose Biosciences has higher earnings, but lower revenue than Neptune Wellness Solutions. Aptose Biosciences is trading at a lower price-to-earnings ratio than Neptune Wellness Solutions, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptose BiosciencesN/AN/A-C$154.69M-C$7.85-0.20Neptune Wellness SolutionsC$48.80M0.00-C$192.95M-C$24.16N/A Do analysts recommend APS or NEPT? Given Neptune Wellness Solutions' higher possible upside, analysts plainly believe Neptune Wellness Solutions is more favorable than Aptose Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aptose Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00Neptune Wellness Solutions 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryAptose Biosciences beats Neptune Wellness Solutions on 7 of the 11 factors compared between the two stocks. Get Aptose Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for APS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APS vs. The Competition Export to ExcelMetricAptose BiosciencesBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$4.01MC$228.28MC$6.12BC$9.47BDividend Yield0.39%3.80%5.66%6.48%P/E Ratio-0.2094.7364.0826.27Price / SalesN/A6,044.23612.7912.91Price / Cash1.6013.1938.5083.29Price / Book-1.71109.9012.725.74Net Income-C$154.69M-C$90.99MC$3.30BC$301.20M7 Day Performance-6.55%0.37%1.05%-0.60%1 Month Performance-6.55%5.63%7.56%5.03%1 Year Performance-89.32%698.25%79.69%39.56% Aptose Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APSAptose BiosciencesN/AC$1.57-1.9%N/A-89.1%C$4.01MN/A-0.2031Gap UpNEPTNeptune Wellness SolutionsN/AN/AN/AN/AC$15.73MC$48.80M-0.08130Gap DownATEAntibe TherapeuticsN/AN/AN/AN/AC$15.64MC$9.71M-0.8411SBMSirona BiochemN/AC$0.06-7.7%N/A-20.0%C$15.41MC$683.77K-6.00N/AGap DownHigh Trading VolumeIMVIMVN/AN/AN/AN/AC$13.12MC$23K-0.1820IOTInnovotechN/AC$0.21+5.0%N/A+44.4%C$10.51MC$3.62M38.291,620Gap UpQPTQuest PharmaTechN/AC$0.05flatN/A+16.7%C$7.61MN/A-25.00147,000Gap DownKNEKane BiotechN/AC$0.05-10.0%N/A-69.2%C$7.48MC$1.85M-0.50N/AGap DownRVVRevive TherapeuticsN/AC$0.08+14.3%N/A+0.0%C$5.79MN/A-3.64N/AGap UpHigh Trading VolumePBSPacgen Life Science Co. (PBS.V)N/AC$0.03+20.0%N/A+0.0%C$1.94MC$302.08K-5.00N/AGap UpMFSMedifocus Inc. (MFS.V)N/AC$0.01flatN/A+0.0%C$1.85MC$2.23M-1.004,800 Related Companies and Tools Related Companies NEPT Competitors ATE Competitors SBM Competitors IMV Competitors IOT Competitors QPT Competitors KNE Competitors RVV Competitors PBS Competitors MFS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:APS) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptose Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptose Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
